Inventor · disambiguated record
Fabio Rancati
Also filed as: RANCATI FABIO
19 granted patents·14 pending applications·24 citations·filing 2011–2022
90Inventor score
Top patents by PatentIndex Score
33 records- 0179US8980913B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2013·Granted Mar 17, 2015·4 cites·10 claims
- 0277US10004728B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Jun 26, 2018·2 cites·12 claims
- 0376US9579314B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Feb 28, 2017·2 cites·14 claims
- 0475US9662323B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 0574US8877774B2Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Nov 4, 2014·4 cites·21 claims
- 0673US9371318B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2015·Granted Jun 21, 2016·1 cites·19 claims
- 0773US9012644B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Apr 21, 2015·3 cites·19 claims
- 0869US8987299B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2013·Granted Mar 24, 2015·4 cites·10 claims
- 0964US10954236B2Tyrosine amide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2019·Granted Mar 23, 2021·0 cites·15 claims
- 1064US8481517B2Pyrrolidine compounds,pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the sameGHIDINI ELEONORA·Filed 2011·Granted Jul 9, 2013·2 cites·15 claims
- 1159US2024425482A1Pyrrolidine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1257US2024092790A1Dihydrofuropyridine derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1357US2024092791A1Dihydrofuropyridine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 1455US2024391936A1Tetrahydrothieno pyridine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1555US2024279240A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1655US2024166651A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1755US2024199635A1Tetrahydrothieno pyridine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1855US2024217967A1Indoline derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 1954US10501461B2Tyrosine amide derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Dec 10, 2019·0 cites·14 claims
- 2054US2024209001A1Heterocyclic derivatives as janus kinase inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2154US2024190847A1Indoline derivatives as ddr1 and ddr2 inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 2253US2023227447A1Benzylamine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2351US2021284639A1Tyrosine amide derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 2450US2024082223A1Dihydrofuropyridine derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2548US11725007B2Meta tyrosine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Aug 15, 2023·0 cites·13 claims
- 2646US11578068B2Oxadiazole derivatives as Rho-Kinase InhibitorsCHIESI FARM SPA·Filed 2018·Granted Feb 14, 2023·0 cites·23 claims
- 2746US11147812B2Tyrosine analogues derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Oct 19, 2021·0 cites·14 claims
- 2845US10584128B2Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2017·Granted Mar 10, 2020·0 cites·14 claims
- 2944US2021253568A1Azaindole derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 3042US11332468B2Azaindole derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted May 17, 2022·0 cites·15 claims
- 3142US9453013B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2015·Granted Sep 27, 2016·0 cites·16 claims
- 3240US10196386B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Feb 5, 2019·0 cites·20 claims
- 3338US9932338B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Apr 3, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Fabio Rancati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →